SEC CRD #802-113386
--> --> 6 Dimensions Capital --> 中文 中文 Investing in the Next Wave of Global Growth Opportunities and Cutting-Edge Innovation in the Life Sciences. Disciplined Investing and Proactive Partnering Approach Investing in the Next Wave of Global Growth Opportunities and Cutting-Edge Innovation in the Life Sciences. Investing in the Next Wave of Global Growth Opportunities and Cutting-Edge Innovation in the Life Sciences. Active Value Creation by Effective Resource Mobilization 6 Dimensions Capital 6 Dimensions Capital is a leading global healthcare investment firm with offices in Boston, San Francisco, Hong Kong and Shanghai. The firm focuses on the investments of healthcare startups or growth stage companies with operations in the U.S., Europe, China, Israel and other countries. We help and enable entrepreneurs to create and grow innovative healthcare businesses for the benefits of patients worldwide. NEWS & EVENTS July 27, 2018 Curon Biopharmaceutical incubated by 6 Dimensions Capital Completed A USD $150 Million First Round of Financing July 16, 2018 Lyvgen Biopharma completing a USD $30 million Series B funding round, which is led by 6 Dimensions Capital March 12, 2018 Centrexion Therapeutics Announces First Patient Dosed in Phase 3 Trial of CNTX-4975 for the Treatment of Moderate to Severe Knee Osteoarthritis Pain April 28th, 2018 As of May 1st, 2018 the 6 Dimensions Capital Shanghai office will be relocated to Block 17, No.999 Huanke Road, Pudong New District. January 20th, 2
SAU YIN CHUNG
CFO
📞 (852)-2805 1580
🔒 Sign up for free to view key contact information
Sign up free →This profile has not yet been verified by the firm. Information may be incomplete or outdated. Claim this profile to take control of your listing.
Check Size
$150M–$150M
Location
GRAND CAYMAN
Claim this profile to complete your information, set investment criteria, and start receiving curated deal flow from sponsors on DEALITHIC.